# An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain

> **NCT00465647** · PHASE4 · COMPLETED · sponsor: **Purdue Pharma LP** · enrollment: 116 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Hydromorphone

## Key facts

- **NCT ID:** NCT00465647
- **Lead sponsor:** Purdue Pharma LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-05
- **Final completion:** 2010-04
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2015-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465647, "An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00465647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*